Clinician Participation in Cadth’s Pan-Canadian Oncology Drug Review: Contribution and Impact on Cancer Drug Funding Recommendations

M. Trudeau; P. Hoskins; T. Reiman; A. Chambers; H. Mai; P. Wheatley-Price

doi:10.3747/co.24.3644

You are currently viewing a new version of our website. To view the old version click .

Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..

Article

1 April 2017

Clinician Participation in Cadth’s Pan-Canadian Oncology Drug Review: Contribution and Impact on Cancer Drug Funding Recommendations

and

Division of Medical Oncology and Hematology, Sunnybrook Odette Cancer Centre, Toronto, ON, Canada

Medical Oncology, BC Cancer Agency, Vancouver, BC, Canada

Department of Oncology, Saint John Regional Hospital, Saint John, NB, Canada

⁴

Pan-Canadian Oncology Drug Review, Canadian Agency for Drugs and Technologies in Health, Toronto, ON, Canada

Curr. Oncol.2017, 24(2), 71-74;https://doi.org/10.3747/co.24.3644

Version Notes

Order Reprints

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

In any given week, media headlines publicize the benefits of a new “breakthrough” cancer drug, with patients and clinicians subsequently advocating for its use. [...]

Article Metrics

Citations

Article Access Statistics

Journal Statistics

Multiple requests from the same IP address are counted as one view.

The Two Solitudes of Primary Care and Cancer Specialist Care: Is There a Bridge?

The Role of Family Physicians in Cancer Care: Perspectives of Primary and Specialty Care Providers